Hepatic actinomycosis (HA) is a rare infection with an indolent course, atypical clinical manifestations, nonspecific laboratory and imaging findings, and challenging diagnosis. We describe a case of a 35-year-old female who developed HA 2 weeks after gastrectomy. In addition, we analyzed clinical characteristics and outcome of 157 additional cases of HA identified in a 60-year literature review. Patients with HA were predominantly male (57%) and more than one-half were between 40 and 70 years of age. The infection was cryptogenic in 80.8% of cases. Risk factors for HA were identified in 63.1% of the patients. Clinical presentation included fever (57.7%), abdominal pain (52.1%), weight loss (45.1%), anorexia (27.5%), fatigue and chills (12.7% each), and malaise (12%) over a 2.35 ± 3.5 months period. Leukocytosis, elevated alkaline phosphatase, erythrocyte sedimentation rate, and C-reactive protein were the most frequent laboratory findings. Radiologic imaging revealed that the right lobe was more frequently affected (62.5%) with a single lesion found in two-thirds of cases. Diagnosis was achieved by histopathologic examination in 70.6% of cases. Cultures yielded Actinomyces in 45 instances, with A. israelii being the most frequent species. Less than one-half of the patients were treated only with antibiotics, while the others received combined medical and surgical treatment. The median duration of antibiotic therapy was 135 days. The presence of multiple lesions or solid tumor-like lesions (without liquefaction) was significantly associated with medical therapy alone. The outcome was favorable in most cases (94%). Although rarely encountered, HA should be considered in patients with a chronic or subacute inflammatory process of the liver to promptly diagnose and treat.

Highlights of the Study

  • Hepatic actinomycosis (HA) is a rare intra-abdominal infection accounting for 15% of cases of actinomycoses.

  • HA is usually cryptogenic and is more common among males and in immunocompetent individuals.

  • Diagnosis of HA is often difficult because of its indolent course and nonspecific clinical presentation and imaging findings.

  • Treatment options include antimicrobial agents, drainage of the abscess, and surgical resection of the necrotic tissue.

Actinomycosis is a chronic suppurative, granulomatous infection caused by non spore-forming, filamentous, anaerobic Gram-positive bacteria of the genus Actinomyces. These microorganisms are part of the commensal flora of the oropharynx and the gastrointestinal and the female genital tract. Disruption of the mucosa may lead to infection. Among pathogenic species, Actinomyces israelii predominates in human infections [1]. Cervicofacial, thoracic, and abdominal actinomycoses are the most frequent clinical forms of the infection in humans. Liver involvement is rare accounting for 15% of the cases of abdominal actinomycosis. The diagnosis of hepatic actinomycosis (HA) is difficult and is often delayed because of its indolent course and the nonspecific clinical and radiological findings [1, 2]. The preoperative rate of diagnosis is less than 10% [3]. Regarding actinomycosis, Cope [4] states that there is “no disease which is so often missed by expert clinicians.” A case of HA in a patient who had undergone gastrectomy is presented here, with a review of all reported cases over the last 60 years.

A 35-year-old woman was admitted to the General Hospital of Rethymno, Greece, with a 5-day history of fever up to 38.3°C, chills, and diarrhea. She had a history of a laparoscopic sleeve gastrectomy 2 weeks earlier.

CT scan of the chest and abdomen revealed a hypodense cystic lesion of 10 × 5.5 cm on the right lobe of the liver suggestive of pyogenic abscess and a small amount of right pleural effusion. The patient was started on piperacillin-tazobactam (4.5 g every 8 h i.v.) and metronidazole (500 mg every 8 h i.v.) and was transferred to the University Hospital of Heraklion. On admission, laboratory tests showed a leukocytosis of 16.1 × 109/L (neutrophils 83%), mild anemia (hemoglobin 10.0 g/dL), elevated gamma-glutamyltransferase level (66 IU/L; normal: <38 IU/L), and elevated C-reactive protein level of 13.29 mg/dL (normal: <0.5 mg/dL). The rest of the tests were normal. On the same day, the patient underwent ultrasound-guided therapeutic and diagnostic aspiration of the liver abscess (Fig. 1). Pus from the abscess cavity was drained through a pigtail catheter, and the pus was sent for microbiological analysis. Gram stain revealed Gram-positive branching filamentous rods consistent with Actinomyces species. Anaerobic cultures yielded pure growth of Actinomyces odontolyticus that was identified using Vitek 2. Identification was further confirmed by matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS), as well as by 16S rRNA gene sequencing analysis. Antimicrobial susceptibility testing was performed by the Etest method, and the results were interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines. The organism was susceptible to penicillin, ampicillin, amoxicillin/clavulanate, piperacillin/tazobactam, cefoxitin, imipenem, meropenem, moxifloxacin, tigecycline, tetracycline, chloramphenicol, and vancomycin and resistant to metronidazole and clindamycin. Once antimicrobial susceptibilities were available, the antibiotics were switched to cefoxitin (1 g every 6 h). The amount of drainage from the pigtail decreased over the following days, and the catheter was removed after 31 days of use. Follow-up abdominal sonography on days 6 and 11 after pus drainage showed progressive shrinkage of the abscess with sizes of 5.7 × 4.9 cm and 4.7 × 2.4 cm. After discharge, amoxicillin-clavulanic acid (1 g every 12 h) was prescribed. A follow-up abdominal CT performed 8 months after discharge showed the complete resolution of the infection.

Fig. 1.

Coronal contrast-enhanced CT image demonstrating the hepatic lesion in the right lobe with a drainage catheter in place (arrow).

Fig. 1.

Coronal contrast-enhanced CT image demonstrating the hepatic lesion in the right lobe with a drainage catheter in place (arrow).

Close modal

We conducted a search (using the PubMed/MEDLINE, Scopus, and ScienceDirect databases) of the medical literature from January 1960 to July 2021, using the following keywords “Hepatic actinomycosis,” OR “liver actinomycosis.” We also included additional cases identified in the references of the cited papers. Articles written in English, Spanish, French, and German were included. We found 157 additional cases, and the following variables were recorded: patients’ demographics, comorbidities, clinical symptoms, radiological characteristics, laboratory findings, causative agent and co-pathogens, method of diagnosis, treatment, and outcome. Percentages were calculated based on the actual number of patients with available data.

Three-quarters of the cases of HA have been reported in the last 30 years. Table 1 summarizes the patients’ demographics and their comorbidities. Ninety patients (57%) were males and 68 (43%) were females. The mean age of patients with HA was 49 ± 18.6 years (range, 4–88 years). Among the 158 HA patients, only 8 were pediatric cases [5-12]. The disease had a worldwide distribution with most cases being reported in Asian countries (36.7%). European and North American countries ranked second and third with 28.5% and 27.8% of cases, respectively.

Table 1.

Characteristics of the 158 patients with hepatic actinomycosis

Characteristics of the 158 patients with hepatic actinomycosis
Characteristics of the 158 patients with hepatic actinomycosis

Predisposing factors for HA were identified in 99 patients (63.1%). Most patients had more than one comorbidity. In particular, remote surgical abdominal or pelvic procedures were described in 32.3% of patients [3, 13-41]. Recent abdominal or pelvic surgery (≤1 year) was reported in 25 cases including intrauterine contraceptive device (IUCD) removal (n = 12) [42-53], appendectomy (n = 3) [54-56], gastrectomy (n = 2) [57], cholecystectomy (n = 3) [34, 37, 58], total pancreatectomy [59], stenting bile and pancreas (n = 2) [29, 60], perforated peptic ulcer (n = 1) [61], and drainage of a rectal abscess (n = 1) [62]. Other predisposing conditions included diabetes mellitus, alcohol abuse, dental caries or abscesses, the use of IUCD, viral hepatitis, chololithiasis and cholangitis, the use of illicit drugs, and end-stage renal disease-in hemodialysis. Most patients (94.9%) were immunocompetent. Only 8 patients had underlying immunosuppressive conditions, including hemodialysis (n = 2) [21, 63], on corticosteroids (n = 4) [17, 64-66], or other immunosuppressive drugs (n = 2) (tacrolimus, hydroxychloroquine) [3, 40]. The infection was cryptogenic and considered as primary in 80.8% of the patients, while in 19 (12.2%), 10 (6.4%), and 1 (0.6%) was secondary to pelvic, abdominal, and pulmonary actinomycosis, respectively.

Fever was the most frequent presenting symptom in 82/142 cases (57.7%). The mean ± SD temperature was 38.6°C ± 1.03°C (range; 36.5°C–41°C). Other symptoms were abdominal pain in 52.1% of the patients, weight loss in 45.1%, anorexia in 27.5%, chills in 12.7%, fatigue in 12.7%, malaise in 12%, night sweats in 10.6%, vomiting in 7.7%, nausea in 4.9%, diarrhea in 4.2%, headache in 2.8%, and myalgias in 1.4% of them. The onset of symptoms was mainly subacute, with a mean ± SD duration of symptoms of 2.35 ± 3.5 months (range, 4 days–2 years). Acute presentation of symptoms (≤2 weeks duration) was observed in only 31 cases (24.6%) [6, 11, 22, 23, 27, 28, 31, 41, 47, 65, 67-85, and the present case].

Findings on physical examination included right upper quadrant tenderness in 49/100 cases (49%), fever in 36/100 cases (36%), hepatomegaly in 30/100 cases (30%), an abdominal mass in 22/100 cases (22%), cachexia in 7/100 (7%), dental caries/periodontal disease in 7/100 cases (7%), and jaundice in 6/100 (6%). Laboratory tests revealed leukocytosis with a left shift in 85.3% of cases. The mean ± SD leukocyte count was 16.9 ± 7.5 × 109/L (range 5.0–47.0 × 109/L). Elevated erythrocyte sedimentation rate and C-reactive protein levels were found in all reported cases (31 and 42 cases, respectively). Elevated alkaline phosphatase was found in 79.4% of cases. Aspartate aminotransferase was reported in 61 cases and was found elevated in 15 cases and slightly elevated in 4. Alanine aminotransferase was reported in 63 cases and was found elevated in 12 cases and slightly elevated in 7. Elevated bilirubin or jaundice was found in 11 cases of the 37 reported [11, 28, 38, 43, 62, 69-73, 86].

Diagnostic radiologic imaging was performed by abdominal ultrasound and CT scan, while magnetic resonance imaging was performed in a small number of cases. The type of lesions included cystic/abscess-like appearance in almost two-thirds of cases, and in the rest, imaging demonstrated a mass, frequently misdiagnosed as primary or metastatic liver cancer. A single lesion was found in 67.1% of patients, and the right lobe was the most commonly affected (62.5%) (Table 2). The infection extended to the surrounding tissues in 78 cases: diaphragm (n = 20), abdominal wall (n = 19), lung (n = 17), pleura (n = 8), colon (n = 5), stomach (n = 3), gallbladder (n = 2), pancreas (n = 2), and kidney (n = 2). Fistulas to the skin (through the abdominal wall), the bronchial tree, the lung, and the pericardial space were described in a limited number of cases [9, 13, 39, 62, 87]. Rare complications included thrombosis or obstruction of the portal vein (n = 8) [29, 43, 45, 88-91], hepatic vein thrombosis (n = 3) [23, 49, 80] and inferior vena cava thrombosis or obstruction (n = 2) [23, 81], cardiac tamponade (n = 3) [28, 92, 93], and gastrointestinal bleed (n = 1) [94].

Table 2.

Radiological and anatomic characteristics of hepatic actinomycosis

Radiological and anatomic characteristics of hepatic actinomycosis
Radiological and anatomic characteristics of hepatic actinomycosis

Diagnosis was confirmed by histopathologic examination of surgical samples in 60 cases: biopsy (n = 26), drainage (n = 11), and resection (n = 23) or percutaneous samples (n = 45): biopsy (n = 33) and drainage (n = 12). Diagnosis was confirmed by postmortem examination of the liver tissue in 4 cases [69, 89, 93, 95]. Cultures of surgical and percutaneous specimens yielded Actinomyces species in 12 and 27 instances, respectively. Diagnosis was confirmed by blood cultures in 3 cases [70, 96, 97] and by culture of both blood and percutaneous drainage sample in 3 other cases [71, 74, 77] (Table 3). Identification to the species level was performed in 32 cases, using either conventional methods, or the API system, the automated VITEK 2 system, MALDI-TOF MS, and 16S rRNA sequencing analysis. Genomic polymerase chain reaction (PCR) analysis was performed in 7 instances [28, 63, 71, 75, 80, 97]. A. israelii was the most frequently isolated species (Table 4). The infection was mixed in 32 cases, and the isolated co-pathogens are shown in Table 4.

Table 3.

Diagnosis of hepatic actinomycosis

Diagnosis of hepatic actinomycosis
Diagnosis of hepatic actinomycosis
Table 4.

Actinomyces species isolated and co-isolates in mixed infections

Actinomyces species isolated and co-isolates in mixed infections
Actinomyces species isolated and co-isolates in mixed infections

Therapy involved antibiotic administration alone (n = 62), combined antibiotic treatment and surgical drainage (n = 21), combined antibiotic treatment and percutaneous drainage (n = 31), combined antibiotic treatment and liver lobe resection (n = 31), and surgery alone (n = 4). The median duration of antibiotic therapy was 135 days (range: 7–730 days). The most frequently administered antibiotics were intravenous penicillin G (60.8%), followed by long-term oral penicillin (26.9%), amoxicillin (19.2%), doxycycline (6.2%), amoxicillin-clavulanic acid (4.6%), or clindamycin (3.8%). Importantly, univariate analysis demonstrated that the presence of multiple lesions or solid tumor-like lesions was significantly associated with medical therapy alone without the need for surgical intervention (Table 5). The majority of patients (94%) responded well to treatment. The mortality rate in relation to types of treatment is presented in Table 6. Mortality was not significantly different (p = 1.0) between those who received combined antibiotic treatment and surgical drainage and those treated with antibiotics alone.

Table 5.

Univariate analysis of clinical and radiological characteristics associated with management of patients with hepatic actinomycosis

Univariate analysis of clinical and radiological characteristics associated with management of patients with hepatic actinomycosis
Univariate analysis of clinical and radiological characteristics associated with management of patients with hepatic actinomycosis
Table 6.

Type of therapy and mortality rate

Type of therapy and mortality rate
Type of therapy and mortality rate

Human actinomycosis was first recognized in 1878 by Israel, who also later identified the microorganism’s cultural characteristics and its anaerobic nature. Actinomycosis has been a common infection in the pre-antibiotic era, but its incidence has decreased with the advent of antibiotics. However, actinomycosis continues to be a problem in developing countries due to the low socioeconomic status and the limited access to medical therapy. Liver involvement is rare, accounting for only 5% of all cases of actinomycosis [1, 2]. Only sporadic cases and case series of HA have been reported. The present review revealed the global distribution of the disease with its burden being higher in Asia, as recently reported [98]. A male predominance (3:2.3) was observed, and most patients were immunocompetent. The peak incidence of the disease is reported to be in the fourth decade of life, with cases being less frequent in children and elderly aged 80 years and above.

Liver involvement may occur via extension from a contiguous abdominal focus or by hematogenous spread via the portal vein following mucosal injury induced by surgical or endoscopic manipulations, ulcer, foreign bodies, intra-abdominal infection, or immunosuppression [1, 2]. One or more comorbidities were observed in more than half of the cases reviewed, with remote abdominal and pelvic surgery and diabetes mellitus being the most common. Nevertheless, most of the cases (80.8%) were cryptogenic.

Symptoms of HA are variable, nonspecific, and indolent with most common manifestations being fever, abdominal pain, weight loss, and anorexia. Laboratory findings include leukocytosis with a left shift, erythrocyte sedimentation rate, C-reactive protein, and alkaline phosphatase elevations. Imaging features are also nonspecific and often mimic primary or metastatic neoplasms [19, 25, 27, 33, 35, 39, 40, 60, 80, 84, 85].

Demonstration of aggregates of filamentous Gram-positive organisms in “sulfur granules” of biopsy specimens or aspirated pus is suggestive of actinomycosis. The isolation in culture of Actinomyces species confirms the diagnosis. However, in a notable percentage of cases, cultures did not yield the causative microorganism. This is due either to previous antimicrobial treatment or to inhibition of growth by other microorganisms, and to inadequate culture conditions and short incubation period of culture specimens. Suitable and adequate sampling, handling, and processing of the samples is necessary for diagnosis. MALDI-TOF provides quick and accurate identification to the genus level, while 16S rRNA sequencing is the reference method for definitive identification. PCR can also be used for direct detection of the microorganism in clinical specimens [2]. A. israelii was the predominant species, while A. odontolyticus, the species isolated from the aspirated pus of our patient, is relatively rare [51, 74, 75]. Other bacterial species were concomitantly isolated in many studies; these “companion microbes” serve as co-pathogens contributing to the inhibition of host immune responses and reducing the oxygen tension [1, 2].

Therapeutic options include antibiotics, drainage of the abscess, and resection of the necrotic tissue. Treatment of the infection with prolonged courses of antibiotics is recommended, to avoid recurrence [2]. Actinomyces are susceptible in vitro to many antibiotics. Penicillin G is the drug of choice and must be given intravenously for 4–6 weeks, followed by oral penicillin V for 6–12 months. Tetracyclines, doxycycline, erythromycin, and cephalosporins are effective alternatives [2]. In case of the presence of co-pathogens, antimicrobial treatment should include coverage of these organisms. In our case, treatment included drainage of the abscess combined with intravenous therapy, followed by a maintenance oral therapy. Of interest, the presence of multiple lesions and solid lesions (without evidence of liquefaction) was significantly associated with conservative management without the need for surgical intervention. The more advanced cases require combined medical therapy and drainage of the abscess or surgical resection of the necrotic tissue for optimal outcome. However, despite the delayed diagnosis, the outcome of HA was excellent in most cases, with a mortality rate of 6%.

HA, although rarely encountered, should be considered in the differential diagnosis of patients with chronic constitutional symptoms and evidence of solitary or multiple hypodense liver lesions and laboratory findings of chronic inflammation. Diagnosis is established by histological examination and cultures or PCR of the exudate and the biopsy or the surgical specimen. Medical therapy alone or combined with surgery has proven to be highly effective for management of this infection.

Written informed consent was obtained from the patient for publication of this case report and accompanying images.

The authors have no conflicts of interest to declare.

The authors did not receive any funding for this study.

1.
Russo
TA
.
Agents of actinomycosis
. In:
Bennett
JE
,
Dolin
R
,
Blaser
MJ
, editors.
Mandell, douglas, and bennett’s principles and practice of infectious diseases
.
Philadelphia, PA
:
Elsevier Saunders
;
2015
. p.
2864
73
. .
2.
Valour
F
,
Sénéchal
A
,
Dupieux
C
,
Karsenty
J
,
Lustig
S
,
Breton
P
,
Actinomycosis: etiology, clinical features, diagnosis, treatment, and management
.
Infect Drug Resist
.
2014
;
7
:
183
97
.
3.
Lall
T
,
Shehab
TM
,
Valenstein
P
.
Isolated hepatic actinomycosis: a case report
.
J Med Case Rep
.
2010
;
4
:
45
. .
4.
Cope
VZ
.
Visceral actinomycosis
.
Br Med J
.
1949
;
2
:
1311
6
. .
5.
Rabusin
M
,
D’Andrea
N
,
Brizzi
F
,
Bussani
R
,
Ventura
A
.
Primary hepatic actinomycosis
.
Pediatr Infect Dis J
.
1996
;
15
:
382
4
. .
6.
Guven
A
,
Kesik
V
,
Deveci
MS
,
Ugurel
MS
,
Ozturk
H
,
Koseoglu
V
.
Post varicella hepatic actinomycosis in a 5-year-old girl mimicking acute abdomen
.
Eur J Pediatr
.
2008
;
167
:
1199
201
. .
7.
Lin
TP
,
Fu
LS
,
Peng
HC
,
Lee
T
,
Chen
JT
,
Chi
CS
.
Intra-abdominal actinomycosis with hepatic pseudotumor and xanthogranulomatous pyelonephritis in a 6-year-old boy
.
Scand J Infect Dis
.
2001
;
33
:
551
3
. .
8.
Shah
HR
,
Williamson
MR
,
Boyd
CM
,
Balachandran
S
,
Angtuaco
TL
,
McConnell
JR
.
CT findings in abdominal actinomycosis
.
J Comput Assist Tomogr
.
1987
;
11
:
466
9
. .
9.
Buyukavci
M
,
Caner
I
,
Eren
S
,
Aktas
O
,
Akdag
R
.
A childhood case of primary hepatic actinomycosis presenting with cutaneous fistula
.
Scand J Infect Dis
.
2004
;
36
:
62
3
. .
10.
Lunia
S
,
Chodos
RB
,
Sundaresh
R
.
Actinomycosis of the liver and 67Ga citrate scintigraphy
.
Clin Nucl Med
.
1976
;
1
(
7
):
263
4
. .
11.
Heneghan
HM
,
Healy
NA
,
Martin
ST
,
Ryan
RS
,
Nolan
N
,
Traynor
O
,
Modern management of pyogenic hepatic abscess: a case series and review of the literature
.
BMC Res Notes
.
2011
;
4
:
80
. .
12.
Liang
ZJ
,
Liang
JK
,
Chen
YP
,
Chen
Z
,
Wang
Y
.
Primary liver actinomycosis in a pediatric patient: a case report and literature review
.
World J Clin Cases
.
2021
;
9
(
20
):
5717
23
. .
13.
Esposti
D
,
Lippolis
A
,
Cipolla
M
,
Bonazzi
M
.
An uncommon cause of pericardial actinomycosis
.
Ital Heart J
.
2000
;
1
:
632
5
.
14.
Alawainati
M
,
Al-Khawaja
S
,
Shawqi
Z
,
Alshaikh
S
.
Disseminated actinomycosis a rare cause of abdominal pain: a case report
.
Oman Med J
.
2020
;
35
:
e117
. .
15.
Foreman
JM
.
Actinomycosis of the liver
.
N Z Med J
.
1963
;
62
:
536
7
.
16.
Goldberg
ND
,
Anthony
WC
,
Yen
MC
,
Hashmi
S
.
Hepatic actinomycosis
.
Md Med J
.
1989
;
38
:
751
2
.
17.
Oe
S
,
Shibata
M
,
Hiura
M
,
Mitsuoka
H
,
Matsuhashi
T
,
Narita
R
,
Refractory primary hepatic actinomycosis with direct infiltration to the diaphragm and thorax: the usefulness of contrast-enhanced ultrasonography
.
Intern Med
.
2014
;
53
:
2073
8
.
18.
Prioleau
PG
,
Brochu
FL
.
Penicillin and épluchage treatment of hepatic actinomycosis
.
Arch Surg
.
1974
;
109
:
426
9
. .
19.
Wayne
MG
,
Narang
R
,
Chauhdry
A
,
Steele
J
.
Hepatic actinomycosis mimicking an isolated tumor recurrence
.
World J Surg Oncol
.
2011
;
9
:
70
. .
20.
Morrow
JD
,
Neuzil
KM
.
Primary hepatic actinomycosis: diagnosis by percutaneous transhepatic needle aspiration
.
J Tenn Med Assoc
.
1993
;
86
:
99
101
.
21.
Cirino
CM
,
Paal
E
,
Gibert
CL
.
An elderly man receiving hemodialysis who had diarrhea, weight loss, and liver mass
.
Clin Infect Dis
.
2007
;
44
:
269306
9
. .
22.
Tambay
R
,
Côté
J
,
Bourgault
AM
,
Villeneuve
JP
.
An unusual case of hepatic abscess
.
Can J Gastroenterol
.
2001
;
15
:
615
7
. .
23.
Wong
JJ
,
Kinney
TB
,
Miller
FJ
,
Rivera-Sanfeliz
G
.
Hepatic actinomycotic abscesses: diagnosis and management
.
Am J Roentgenol
.
2006
;
186
:
174
6
. .
24.
Grossen
A
,
Magguilli
M
,
Thai
TC
,
Salem
G
.
Hepatic actinomycosis in a patient with retained common bile duct stent
.
ACG Case Rep J
.
2019
;
6
:
e00219
. .
25.
Nozawa
Y
,
Takamura
M
,
Kamimura
H
,
Tsuchiya
A
,
Terai
S
.
A case of primary hepatic actinomycosis difficult to distinguish from malignant hepatic tumors
.
Kanzo
.
2020
;
61
:
109
15
.
26.
Castellón Pavón
CJ
,
Foruria Franco
AM
,
González Núñez
MA
,
Morales Artero
S
,
Martínez Sapiña
A
,
del Amo Olea
E
.
Actinomicosis hepática primaria Primary hepatic actinomycosis
.
Gastroenterol Hepatol
.
2004
;
27
:
464
6
.
27.
Kanellopoulou
T
,
Alexopoulou
A
,
Tiniakos
D
,
Koskinas
J
,
Archimandritis
AJ
.
Primary hepatic actinomycosis mimicking metastatic liver tumor
.
J Clin Gastroenterol
.
2010
;
44
:
458
9
. .
28.
Llenas-García
J
,
Lalueza-Blanco
A
,
Fernández-Ruiz
M
,
Villar-Silva
J
,
Ochoa
M
,
Lozano
F
,
Primary hepatic actinomycosis presenting as purulent pericarditis with cardiac tamponade
.
Infection
.
2012
;
40
:
339
41
.
29.
Harsch
IA
,
Benninger
J
,
Niedobitek
G
,
Schindler
G
,
Schneider
HT
,
Hahn
EG
,
Abdominal actinomycosis: complication of endoscopic stenting in chronic pancreatitis?
Endoscopy
.
2001
;
33
:
1065
9
.
30.
Saad
M
,
Moorman
J
.
Images in clinical medicine. Actinomyces hepatic abscess with cutaneous fistula
.
N Engl J Med
.
2005
;
353
:
e16
. .
31.
Logan
MN
,
Stanley
PJ
,
Exley
A
,
Gagg
C
,
Farrell
ID
.
Actinomycetes in pyogenic liver abscess
.
Eur J Clin Microbiol Infect Dis
.
1989
;
8
:
394
6
. .
32.
Jermini-Gianinazzi
I
,
Luethy
R
,
Gubler
J
.
An unusual case of hepatic abscess
.
Praxis
.
2004
;
93
:
1781
4
. .
33.
Aslan
A
,
Ayaz
E
,
Inan
I
,
Acar
M
.
Isolated hepatic actinomycosis mimicking hepatocellular carcinoma: case report and review
.
Adv Dig Med
.
2018
;
5
(
1–2
):
55
8
. .
34.
Chen
LW
,
Chang
LC
,
Shie
SS
,
Chien
RN
.
Solitary actinomycotic abscesses of liver: report of two cases
.
Int J Clin Pract
.
2006
;
60
:
104
7
. .
35.
Ridha
A
,
Oguejiofor
N
,
Al-Abayechi
S
,
Njoku
E
.
Intra-abdominal actinomycosis mimicking malignant abdominal disease
.
Case Rep Infect Dis
.
2017
;
2017
:
1972023
. .
36.
Sahay
S
,
McKelvy
BJ
.
Actinomycosis presenting as recurrent hepatic abscess
.
Am J Med
.
2017
;
130
:
e21
2
. .
37.
Xing
J
,
Rodriguez
EF
,
Monaco
SE
,
Pantanowitz
L
.
Cytopathology of hepatobiliary-related actinomycosis
.
Acta Cytol
.
2016
;
60
:
179
84
. .
38.
Islam
T
,
Athar
MN
,
Athar
MK
,
Usman
MH
,
Misbah
B
.
Hepatic actinomycosis with infiltration of the diaphragm and right lung: a case report
.
Can Respir J
.
2005
;
12
:
336
7
. .
39.
Mzoughi
Z
,
Hfaiedh
R
,
Ben Abid
S
,
Miloudi
N
,
Marsaoui
L
,
Arfa
N
,
Actinomycose hépatique a rare hepatic tumor: hepatic actinomycosis
.
Tunis Med
.
2013
;
91
:
219
20
.
40.
Kothadia
JP
,
Samant
H
,
Olivera-Martinez
M
.
Actinomycotic hepatic abscess mimicking liver tumor
.
Clin Gastroenterol Hepatol
.
2018
;
16
:
e86
. .
41.
Min
KW
,
Paik
SS
,
Han
H
,
Jang
KS
.
Education and imaging. Hepatobiliary and pancreatic: hepatic actinomycosis
.
J Gastroenterol Hepatol
.
2012
;
27
:
844
. .
42.
Kim
HS
,
Park
NH
,
Park
KA
,
Kang
SB
.
A case of pelvic actinomycosis with hepatic actinomycotic pseudotumor
.
Gynecol Obstet Invest
.
2007
;
64
(
2
):
95
9
. .
43.
White
JE
,
Chase
CW
,
Kelley
JE
,
Brock
WB
,
Clark
MO
.
Inflammatory pseudotumor of the liver associated with extrahepatic infection
.
South Med J
.
1997
;
90
(
1
):
23
9
. .
44.
Emre
A
,
Carilli
S
,
Hazar
H
,
Ince
U
,
Calangu
S
.
Hepatic involvement of disseminated actinomycosis
.
J Hep Bil Pancr Surg
.
1997
;
4
(
3
):
337
9
. .
45.
Yu
CY
,
Chang
WC
,
Gao
HW
,
Chao
TY
,
Huang
GS
,
Hsieh
CB
.
Metastatic hepatic actinomycosis
.
Am J Med
.
2010
;
123
(
9
):
e9
e11
. .
46.
Hung-Wei
C
,
Yang
YS
,
Lin
TY
,
Jung-Chung
L
,
Feng-Yee
C
,
Wang
NC
.
Tubo-ovarian actinomycosis complicated with hepatic abscess
.
J Med Sci
.
2010
;
30
(
6
):
261
4
.
47.
Sheth
S
,
Fishman
EK
,
Sanders
R
.
Actinomycosis involving the liver. Computed tomography/ultrasound correlation
.
J Ultrasound Med
.
1987
;
6
(
6
):
329
31
. .
48.
Abid
M
,
Amar
MB
,
Feriani
N
,
Damak
Z
,
Cheikhrouhou
H
,
Khalif
M
,
Actinomycose pelvienne pseudotumorale pelvic pseudotumoral actinomycosis: two cases
.
Rev Med Interne
.
2010
;
31
(
3
):
232
5
.
49.
Ishiguro
T
,
Takayanagi
T
,
Ikarashi
H
.
Multiple metastatic liver abscesses and intravenous thrombosis due to pelvic actinomycosis
.
Eur J Obstet Gynecol Reprod Biol
.
2016
;
198
:
166
7
. .
50.
Andersen
AB
,
Ravn
P
,
Kahn
R
,
Rosted
A
,
Philipsen
EK
.
Hepatic actinomycosis. A case report
.
APMIS
.
1999
;
107
:
225
30
. .
51.
Ruutu
P
,
Pentikäinen
PJ
,
Larinkari
U
,
Lempinen
M
.
Hepatic actinomycosis presenting as repeated cholestatic reactions
.
Scand J Infect Dis
.
1982
;
14
:
235
8
. .
52.
Shurbaji
MS
,
Gupta
PK
,
Newman
MM
.
Hepatic actinomycosis diagnosed by fine needle aspiration. A case report
.
Acta Cytol
.
1987
;
31
:
751
5
.
53.
Granger
JK
,
Houn
HY
.
Diagnosis of hepatic actinomycosis by fine-needle aspiration
.
Diagn Cytopathol
.
1991
;
7
:
95
7
. .
54.
Golematis
B
,
Hatzitheofilou
C
,
Melissas
J
.
Liver actinomycosis: a case report
.
Am J Gastroenterol
.
1976
;
65
:
148
.
55.
Sharma
M
,
Briski
LE
,
Khatib
R
.
Hepatic actinomycosis: an overiew of salient features and outcome
.
Scand J Infect Dis
.
2002
;
34
:
386
91
.
56.
Hayashi
M
,
Asakuma
M
,
Tsunemi
S
,
Inoue
Y
,
Shimizu
T
,
Komeda
K
,
Surgical treatment for abdominal actinomycosis: a report of two cases
.
World J Gastrointest Surg
.
2010
;
2
:
405
8
.
57.
Ha
YJ
,
An
JH
,
Shim
JH
,
Yu
ES
,
Kim
JJ
,
Ha
TY
,
A case of primary hepatic actinomycosis: an enigmatic inflammatory lesion of the liver
.
Clin Mol Hepatol
.
2015
;
21
:
80
4
.
58.
Galindo
JL
,
Fajardo
E
,
Ojeda
P
,
Carrillo
JA
.
Abscesos hepáticos múltiples y empiema: una presentación inusual de actinomicosis
.
Infectio
.
2017
;
21
:
61
4
.
59.
Sakaguchi
T
,
Hashimoto
D
,
Satoi
S
,
Yamamoto
T
,
Yamaki
S
,
Sekimoto
M
.
Hepatic actinomycosis after total pancreatectomy: a case report
.
Int J Surg Case Rep
.
2021
;
85
:
106212
. .
60.
Lange
CM
,
Hofmann
WP
,
Kriener
S
,
Jacobi
V
,
Welsch
C
,
Just-Nuebling
G
,
Primary actinomycosis of the liver mimicking malignancy
.
Z Gastroenterol
.
2009
:
1062
4
.
61.
Pheils
MT
,
Reid
DJ
,
Ross
CF
.
Abdominal actinomycosis
.
Br J Surg
.
1964
;
51
:
345
50
. .
62.
Forgan-Smith
JR
,
Mowat
P
,
Strutton
G
.
A report of actinomycosis involving the lung and liver
.
Med J Aust
.
1989
;
150
:
153
5
.
63.
Uehara
Y
,
Takahashi
T
,
Yagoshi
M
,
Shimoguchi
K
,
Yanai
M
,
Kumasaka
K
,
Liver abscess of Actinomyces israelii in a hemodialysis patient: case report and review of the literature
.
Intern Med
.
2010
;
49
:
2017
20
.
64.
Lee
JH
,
Kim
HS
,
Kim
JS
,
Lee
DK
,
Lim
JH
.
Hepatic actinomycosis with immunoglobulin G4-related liver disease: a case report
.
Medicine
.
2018
;
97
:
e11146
. .
65.
Roesler
PJ
 Jr
,
Wills
JS
.
Hepatic actinomycosis: CT features
.
J Comput Assist Tomogr
.
1986
;
10
:
335
7
. .
66.
Chung
JW
,
Bae
YS
,
Lim
JH
,
DongLee
K
,
Yu
JS
.
IgG4-related hepatic inflammatory pseudotumor complicated by actinomycosis during steroid therapy
.
J Korean Soc Radiol
.
2019
;
80
:
351
8
.
67.
Nadal
HM
,
Munoz
M
.
Actinomycosis of the liver
.
Bol Asoc Med P R
.
1965
;
57
:
225
9
.
68.
Brewer
JH
,
Allen
MJ
.
Actinomycosis of the gallbladder with liver abscess
.
South Med J
.
1980
;
73
:
1070
2
. .
69.
Serrano-Rios
M
,
Navarro
V
,
Fontan
J
,
Oliva
H
,
Ramirez
J
.
Isolated hepato-pancreatic actinomycosis. Report of a case stimulating an acute abdomen of fatal course
.
Digestion
.
1969
;
2
:
262
71
. .
70.
Mongiardo
N
,
De Rienzo
B
,
Zanchetta
G
,
Lami
G
,
Pellegrino
F
,
Squadrini
F
.
Primary hepatic actinomycosis
.
J Infect
.
1986
;
12
:
65
9
. .
71.
Riegert-Johnson
DL
,
Sandhu
N
,
Rajkumar
SV
,
Patel
R
.
Thrombotic thrombocytopenic purpura associated with a hepatic abscess due to Actinomyces turicensis
.
Clin Infect Dis
.
2002
;
35
:
636
7
. .
72.
Correa Bonito
A
,
Mora-Guzmán
I
,
García-Sanz
I
,
di Martino
M
,
Martín-Pérez
E
.
Liver abscess after endoscopic retrograde cholangiopancreatography with presence of Actinomyces naeslundii
.
Cir Esp
.
2017
;
95
:
51
2
. .
73.
Jaqua
NT
,
Smith
AJ
,
Shin
TT
,
Jahanmir
J
.
Actinomyces naeslundii and Eikenella corrodens as rare causes of liver abscesses
.
BMJ Case Rep
.
2013
;
2013
:
bcr2013009613
. .
74.
Cavrić
G
,
Nasabain
K
,
Jurić
K
,
Prkačin
I
,
Bartolek Hamp
D
,
Bogdanović Dvorščak
M
.
Liver abscess caused by Actinomyces odontolyticus, Abiotrophia species, Haemophilus parainfluenzae, Streptococcus anginosus i Streptococcus intermedius: case report
.
Signa Vitae
.
2015
;
10
(
Suppl 1
):
S72
3
.
75.
Chao
CT
,
Liao
CH
,
Lai
CC
,
Hsueh
PR
.
Liver abscess due to Actinomyces odontolyticus in an immunocompetent patient
.
Infection
.
2011
;
39
:
77
9
. .
76.
Ciria-Bru
R
,
Naranjo-Torres
A
,
Sánchez-Hidalgo
JM
,
Briceño-Delgado
J
,
López-Cillero
P
.
Right hepatectomy due to hepatic actinomycosis
.
Cir Esp
.
2008
;
83
:
327
8
. .
77.
García-Corbeira
P
,
Esteban-Moreno
J
.
Liver abscess due to Actinomyces meyeri
.
Clin Infect Dis
.
1994
;
18
:
491
2
.
78.
Lakshmana Kumar
YC
,
Javherani
R
,
Malini
A
,
Prasad
SR
.
Primary hepatic actinomycosis
.
Trans R Soc Trop Med Hyg
.
2005
;
99
:
868
70
. .
79.
Miyamoto
MI
,
Fang
FC
.
Pyogenic liver abscess involving Actinomyces: case report and review
.
Clin Infect Dis
.
1993
;
16
:
303
9
. .
80.
Murphy
P
,
Mar
WA
,
Allison
D
,
Cornejo
GA
,
Setty
S
,
Giulianotti
PC
.
Hepatic actinomycosis: a potential mimicker of malignancy
.
Radiol Case Rep
.
2019
;
15
:
105
9
. .
81.
Petrache
D
,
Popescu
GA
.
Successful switch to oral therapy with doxycycline in the case of an actinomycotic hepatic abscess
.
J Infect Dev Ctries
.
2013
;
7
:
421
3
. .
82.
Soardo
G
,
Basan
L
,
Intini
S
,
Avellini
C
,
Sechi
LA
.
Elevated serum CA 19-9 in hepatic actinomycosis
.
Scand J Gastroenterol
.
2005
;
40
:
1372
3
. .
83.
Sugano
S
,
Matuda
T
,
Suzuki
T
,
Makino
H
,
Iinuma
M
,
Ishii
K
,
Hepatic actinomycosis: case report and review of the literature in Japan
.
J Gastroenterol
.
1997
;
32
:
672
6
.
84.
Yang
SS
,
Im
YC
.
Severe abdominopelvic actinomycosis with colon perforation and hepatic involvement mimicking advanced sigmoid colon cancer with hepatic metastasis: a case study
.
BMC Surg
.
2018
;
18
:
51
. .
85.
Zeng
QQ
,
Zheng
XW
,
Wang
QJ
,
Yu
ZP
,
Zhang
QY
.
Primary hepatic actinomycosis mimicking liver tumour
.
ANZ J Surg
.
2018
;
88
:
E629
30
. .
86.
Felekouras
E
,
Menenakos
C
,
Griniatsos
J
,
Deladetsima
I
,
Kalaxanisi
N
,
Nikiteas
N
,
Liver resection in cases of isolated hepatic actinomycosis: case report and review of the literature
.
Scand J Infect Dis
.
2004
;
36
:
535
8
.
87.
Biggs
JSG
.
Actinomycosis of the liver: a report of two cases
.
Med J Aust
.
1960
;
2
(
24
):
939
40
. .
88.
Cheng
YF
,
Hung
CF
,
Liu
YH
,
Ng
KK
,
Tsai
CC
.
Hepatic actinomycosis with portal vein occlusion
.
Gastrointest Radiol
.
1989
;
14
:
268
70
. .
89.
Lu
CL
,
Hwang
SJ
,
Chang
CF
,
Wu
JC
,
Chiang
H
,
Chiang
JH
,
Hepatic actinomycosis with portal vein thrombosis mimicking hepatocellular carcinoma: a case report
.
Zhonghua Yi Xue Za Zhi
.
1993
;
51
:
381
5
.
90.
Nazarian
LN
,
Spencer
JA
,
Mitchell
DG
.
Multiple actinomycotic liver abscesses: MRI appearances with etiology suggested by abdominal radiography. Case report
.
Clin Imaging
.
1994
;
18
:
119
22
. .
91.
Nemcek
AA
 Jr
,
Vogelzang
RL
.
SIR 2004 film panel case: hepatic actinomycosis from pelvic inflammatory disease causing portal vein thrombosis
.
J Vasc Interv Radiol
.
2004
;
15
:
1363
5
. .
92.
Sakaguchi
Y
,
Isowa
N
,
Nakazaki
H
,
Takeda
K
,
Tokuyasu
H
,
Saitoh
Y
,
Acute cardiac tamponade caused by the extension of multiple hepatic actinomycotic abscesses
.
Intern Med
.
2012
;
51
:
305
8
.
93.
Olds
KL
,
Gilbert
JD
,
Byard
RW
.
Actinomyces in forensic practice
.
Am J Forensic Med Pathol
.
2021
;
42
(
2
):
191
3
. .
94.
Chandarlapaty
SK
,
Dusol
M
 Jr
,
Edwards
R
,
Pereiras
R
 Jr
,
Clark
R
,
Schiff
ER
.
67Gallium accumulation in hepatic actinomycosis
.
Gastroenterology
.
1975
;
69
:
752
5
. .
95.
Powell
G
,
Mangalika
M
.
Thoraco-pulmonary and hepatic actinomycosis: an autopsy report
.
BMJ Case Rep
.
2011
;
2011
:
bcr0920114831
. .
96.
van Marion
WF
,
Thompson
J
,
Mouton
RP
,
Ottenhoff
TM
,
van Furth
R
.
Successful single antibiotic therapy in Actinomyces septicemia and liver abscess
.
Infection
.
1982
;
10
:
287
9
. .
97.
Seo
JY
,
Yeom
JS
,
Ko
KS
.
Actinomyces cardiffensis septicemia: a case report
.
Diagn Microbiol Infect Dis
.
2012
;
73
:
86
8
. .
98.
Chegini
Z
,
Didehdar
M
,
Tabaeian
SP
,
Khoshbayan
A
,
Shariati
A
.
A systematic review of case reports of hepatic actinomycosis
.
Orphanet J Rare Dis
.
2021
;
16
(
1
):
192
. .
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.